Novo Nordisk A/S | NOVOB - 流動資産





流動資産 変化する 日付
Bausch Health Companies USD 6.16B 92M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Eli Lilly USD 55.63B 6.44B 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
Merck USD 47.56B 10.49B 2025-09
Novartis USD 30.46B 2.26B 2025-12
Novo Nordisk DKK 172.45B 9.43B 2025-12
Novo Nordisk DKK 25.71B 148.69B 2025-06
Pacira USD 547.97M 14.78M 2025-12
Sanofi EUR 30.95B 3.09B 2025-12
Supernus Pharmaceuticals USD 644.18M 50.29M 2025-12